BioCentury
ARTICLE | Emerging Company Profile

Getting past PTSD

How Neurovation’s GRIA1 programs could improve PTSD diagnosis and treatment

June 21, 2018 6:29 PM UTC

Neurovation Labs Inc. is developing a GRIA1-targeting tracer and a small molecule therapy that could provide an objective diagnosis of PTSD and treat the underlying disease instead of just its symptoms.

Post-traumatic stress disorder (PTSD) is diagnosed with a symptom checklist that is typically self-reported and therefore not objective. ...



Access The Full Article